| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) | 
|---|
| 12/23/1998 | EP0885046A1 Filtration of plasma mixtures using cellulose-based filter aids | 
| 12/23/1998 | EP0885018A1 Method and apparatus for inactivating contaminants in biological fluid | 
| 12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses | 
| 12/23/1998 | EP0885007A1 Method for separating cells, especially platelets, and bag assembly therefor | 
| 12/23/1998 | EP0851784A4 Blood processing systems and methods for collecting mono nuclear cells | 
| 12/23/1998 | EP0623022B1 Formulation and use of microorganisms in treating livestock | 
| 12/23/1998 | CN1202934A Delivery of biologically active polypeptides | 
| 12/23/1998 | CN1202931A Tumour vaccine and process for the preparation thereof | 
| 12/23/1998 | CN1202823A Hydrolysis-optimized liplid emulsions and use thereof | 
| 12/23/1998 | CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains | 
| 12/23/1998 | CN1202522A New strain of Bacillus licheniformis and its microecology preparation | 
| 12/23/1998 | CN1202520A 血清滋补酒 Serum tonic | 
| 12/23/1998 | CN1202369A Smoking stopping powder for whole life | 
| 12/23/1998 | CN1202368A Chinese drug composition for curing gastritis and other stomachache | 
| 12/23/1998 | CN1202360A Frostbite medicine of biological material and producing process thereof | 
| 12/23/1998 | CA2293299A1 Compact epstein-barr virus replicons | 
| 12/22/1998 | US5852054 Fungicidal toxins from biocontrol bacteria | 
| 12/22/1998 | US5852033 Methods of treatment using lamellarin-class alkaloids | 
| 12/22/1998 | US5851985 Treatment of tumors by arginine deprivation | 
| 12/22/1998 | US5851832 In vitro growth and proliferation of multipotent neural stem cells and their progeny | 
| 12/22/1998 | US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells | 
| 12/22/1998 | US5851806 Complementary adenoviral systems and cell lines | 
| 12/22/1998 | US5851756 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens | 
| 12/22/1998 | US5851534 Methods for prevention and/or treatment of neutropenia | 
| 12/22/1998 | US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | 
| 12/22/1998 | US5851521 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis | 
| 12/20/1998 | CA2235444A1 Novel compounds | 
| 12/20/1998 | CA2235441A1 Novel compounds | 
| 12/20/1998 | CA2235437A1 Novel compounds | 
| 12/20/1998 | CA2235422A1 Novel compounds | 
| 12/20/1998 | CA2218852A1 Expression system for production of therapeutic proteins | 
| 12/17/1998 | WO1998056941A1 Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof | 
| 12/17/1998 | WO1998056939A1 Streptomyces avermitilis strain, method for separating avermectin complexes and preparations for protecting plants and animals | 
| 12/17/1998 | WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response | 
| 12/17/1998 | WO1998056896A1 Method of attenuating viruses | 
| 12/17/1998 | WO1998056397A1 Weight control composition comprising hypericum perforatum | 
| 12/17/1998 | WO1998056394A1 Compositions useful as fibrin sealants | 
| 12/17/1998 | WO1998056393A1 Transplantation of immortalized dopamine cells to improve neurological deficits | 
| 12/17/1998 | WO1998056247A1 Platelet suspensions and methods for resuspending platelets | 
| 12/17/1998 | WO1998040087A3 USE OF HUMAN α1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION | 
| 12/17/1998 | WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof | 
| 12/17/1998 | CA2293499A1 Compositions useful as fibrin sealants | 
| 12/17/1998 | CA2290389A1 Platelet suspensions and methods for resuspending platelets | 
| 12/16/1998 | EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML) | 
| 12/16/1998 | EP0884385A1 Intracellular modulators of apoptopic cell death pathways | 
| 12/16/1998 | EP0883684A1 Method of purifying thrombin-like protease enzymes obtained from snake venom | 
| 12/16/1998 | EP0883406A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular | 
| 12/16/1998 | CN1202085A Unactivated oocytes as cytoplast recipients for nuclear transfer | 
| 12/16/1998 | CN1202084A Quiescent cell populations for nuclear transfer | 
| 12/16/1998 | CN1201693A Chick lecithal immune globulin products against rolavirus and its use and its testing method of activity | 
| 12/16/1998 | CN1201680A Pill for pelvic inflammation and cervical erosion | 
| 12/16/1998 | CN1201671A Medicinal cream for curing myopia and weak visual acuity | 
| 12/16/1998 | CN1201668A Fetal membrane as medicine to treat burned and scalded woulds | 
| 12/16/1998 | CN1201667A Infusion for burn and scald | 
| 12/16/1998 | CN1201666A Capsule of cartilage powder of shart and preparation thereof | 
| 12/16/1998 | CN1201664A Improvements in and relating to tablet manufacture | 
| 12/16/1998 | CN1041169C Quick-acting enterogastritis medicine and preparing process thereof | 
| 12/16/1998 | CN1041168C Earthworm component extracting process | 
| 12/15/1998 | US5849987 Animal model for hepatitis virus infection | 
| 12/15/1998 | US5849696 Composition and method of treating hepatitis C | 
| 12/15/1998 | US5849589 Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells | 
| 12/15/1998 | US5849588 Methods of use of a three-dimensional liver cell and tissue culture system | 
| 12/15/1998 | US5849586 Infective protein delivery system | 
| 12/15/1998 | US5849585 Isolating and culturing Schwann cells | 
| 12/15/1998 | US5849584 Cell cultures of and cells culturing method for nontransformed parotid cells | 
| 12/15/1998 | US5849349 Anti-cholesterolemic egg, vaccine and method for production, and use | 
| 12/15/1998 | US5849336 Method using sturgeon notochord for alleviating the symptoms of arthritis | 
| 12/15/1998 | US5849334 Composition comprising a local anesthetic and emu oil and methods of use thereof | 
| 12/15/1998 | US5849295 Nucleotide sequences coding for a protein with urease activity | 
| 12/15/1998 | US5849288 Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells | 
| 12/15/1998 | US5849285 Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells | 
| 12/15/1998 | CA1340270C Thrombolytic composition and a process for production thereof | 
| 12/15/1998 | CA1340236C Method of preparing highly purified alpha-1-proteinage inhibitor | 
| 12/15/1998 | CA1340222C Preparations of placenta collagen, their extraction method and their applications | 
| 12/10/1998 | WO1998055641A2 Somatic gene therapy to suppress secondary cataract formation | 
| 12/10/1998 | WO1998055607A2 Tumor targeted vector | 
| 12/10/1998 | WO1998055598A1 A METHOD OF INHIBITING CANCER CELL GROWTH USING A VECTOR EXPRESSING pRb2/p130 | 
| 12/10/1998 | WO1998055594A2 Methods for chondrocyte growth and differentiation | 
| 12/10/1998 | WO1998055493A1 Natural antitumor or antiviral substances and use of the same | 
| 12/10/1998 | WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use | 
| 12/10/1998 | WO1998055143A1 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein | 
| 12/10/1998 | WO1998055131A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus | 
| 12/10/1998 | WO1998055129A1 Anti-coagulation of blood, blood plasma or synovial fluid products | 
| 12/10/1998 | WO1998054982A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids | 
| 12/10/1998 | WO1998054981A1 Method for administering viable microorganism composition for poultry | 
| 12/10/1998 | WO1998054966A1 A method of treating cancer | 
| 12/10/1998 | WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof | 
| 12/10/1998 | CA2292760A1 Vector | 
| 12/10/1998 | CA2292595A1 Anti-coagulation of blood, blood plasma or synovial fluid products | 
| 12/10/1998 | CA2292536A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids | 
| 12/10/1998 | CA2292471A1 A method of treating cancer | 
| 12/10/1998 | CA2291623A1 Pharmaceutical preparation comprising lactobacillus casei rhamnosus | 
| 12/10/1998 | CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use | 
| 12/10/1998 | CA2234411A1 Novel compounds | 
| 12/09/1998 | EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof | 
| 12/09/1998 | EP0882465A2 Method and apparatus for obtaining a platelet suspension with reduced leukocytes | 
| 12/09/1998 | EP0882464A2 Method and apparatus for obtaining a platelet suspension with reduced leukocytes | 
| 12/09/1998 | EP0882463A1 Adsorbent for immunoglobulins and complexes thereof, adsorption method, and adsorption device | 
| 12/09/1998 | EP0882455A1 Virus-inactivated blood product | 
| 12/09/1998 | EP0882448A1 Method of encapsulating biologically active agents within erythrocytes and apparatus therefor |